Biotechnology company
Appears in 1 story
Leads the Reversible Ambient Biostabilization (RAB) team
ARPA-H committed up to $87 million to a four-year program aiming to store living cell therapies at room temperature, ending the cold chain that defines modern biologics. CaseBioscience, a Colorado biopreservation firm, announced Oct. 2 that it joined one of three funded teams, led by Likarda, awarded up to $7.3 million.
Updated 1 hour ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
